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Children in the UK suffer 100,000 fractures annually ac-
counting for 10% of attendances at accident and emergency
departments1. The incidence of childhood fractures has in-
creased in the last 30 years by approximately 40%2 and 20-
30% of children who fracture are likely to fracture again3-5.
Evidence suggests that children with narrower, i.e. more slen-
der bones and a low bone mass are more likely to fracture than
children with larger, wider bones6,7. Studies have shown that
mechanical loading in childhood can increase bone size and
mass8-10, and that these gains can persist into adult life11-13, po-
tentially improving skeletal health across all ages.
Whole body vibration (WBV) delivered via vibrating plat-
forms has been investigated as a technique to load bone, with
the desired outcome of increasing bone size and strength. The
vibratory stimulus provided differs between platforms. One
type is designed to mimic low level postural strains that form
a dominant component of the skeleton’s 24 hour strain his-
tory14, low magnitude, high frequency synchronous (vertical)
vibration. The second type is designed to fatigue muscle and
stimulate increases in loading to bone via the muscle by ap-
plying high magnitude, high frequency vibration that can be
delivered in a synchronous or side-alternating motion. The ma-
jority of animal investigations have employed low magnitude
high frequency WBV, and demonstrated increased bone den-
sity, size, formation, and strength14-22. Clinical studies over 6-
12 month periods of children with disabling conditions such
as cerebral palsy, young women with low bone mass and
women with post-menopausal osteoporosis have also shown
increased bone mass at the tibia, femur, and spine using syn-
chronous, low magnitude, high frequency WBV23-25 and at the
femoral neck and hip using asynchronous high magnitude,
high frequency WBV26,27. However findings across the studies
are not conclusive, either in terms of the size of the effect or
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The skeleton responds to mechanical stimulation. We wished to ascertain the magnitude and speed of the growing skeleton’s
response to a standardised form of mechanical stimulation, vibration. 36 prepubertal boys stood for 10 minutes in total on one of
two vibrating platforms (high (>2 g) or low (<1 g) magnitude vibration) on either 1, 3 or 5 successive days (n=12 for each dura-
tion); 15 control subjects stood on an inactive platform. Blood samples were taken at intervals before and after vibration to
measure bone formation (P1NP, osteocalcin) and resorption (CTx) markers as well as osteoprotegerin and sclerostin. There were
no significant differences between platform and control groups in bone turnover markers immediately after vibration on days 1,
3 and 5. Combining platform groups, at day 8 P1NP increased by 25.1% (CI 12.3 to 38.0; paired t-test p=0.005) and bone resorption
increased by 10.9% (CI 3.6 to 18.2; paired t-test p=0.009) compared to baseline. Osteocalcin, osteoprotogerin and sclerostin did
not change significantly. The growing skeleton can respond quickly to vibration of either high or low magnitude. Further work
is needed to determine the utility of such “stimulation-testing” in clinical practice.
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its site specificity, and a number of studies have failed to show
any skeletal benefits at all28-31. 
Adult studies suggest that WBV has little or no effect on
bone outcomes in apparently healthy subjects when given 2-7
times a week for up to 12 months29,30,32,33. We know from ex-
ercise studies that the response to loading is greater in children
than in adults however, suggesting that children may also have
a greater capacity for a bone response to vibration. There are
no published data on the acute effect of vibration on the ap-
parently healthy growing skeleton. It is not known if the bone
response to vibration in such children would be similar to that
seen for children with reduced bone mass. 
An alternative use for vibration would be as part of a stim-
ulatory test to assess the skeleton’s responsiveness to mechan-
ical loading, similar to cardiac stress testing using a treadmill.
There could be advantages to such a form of testing if acute
changes in bone formation or resportion were predictive of
longer term response to either pharmacological or mechanical
interventions. The response to mechanical loading before, dur-
ing and after intervention could be assessed in a variety of dis-
ease states both within individuals and between groups of
individuals. Such a test could also be used in assessing out-
comes for phase II studies of bone-targeted compounds to re-
assure investigators that their intervention had not abrogated
responses to mechanical loading. 
We wanted to determine the extent and timing of any
changes in bone turnover markers following very short periods
of WBV and whether this was influenced by the type of vibra-
tion stimulus, either high magnitude or low magnitude, used.
This is a pragmatic approach, reflecting the fact that these two
types of machine, providing either high magnitude, side-alter-
nating (signal intensity >2.0 g) or low magnitude, vertical (sig-
nal intensity <1.0 g) vibration are widely available, but nothing
is known as to their short term effects on bone metabolism.
We undertook thermal imaging of calf muscles as a proxy for
muscle activation34 to determine if this was similar between
the high and low magnitude vibration groups. The overall aim
of this study therefore was to assess the acute response of bone
to low and high magnitude WBV in the growing skeleton.
!*;.92*4: *6- 5.;17-:
The study was approved by the South Humber Local Re-
search Ethics Committee and was carried out in accordance
with the Declaration of Helsinki. Informed written consent was
obtained from the parents, and written assent from the study
participants.
&>?.C :+<>3-3:+8>=
Healthy white Caucasian pre-pubertal boys (Tanner stage
1) aged 9-12 years were recruited to the study by invitation
letters which were handed out in local schools and through
staff at local university hospitals. Boys with a history of bone
disease or other chronic illness, those currently taking med-
ication known to affect bone and those who had previously
fractured were excluded from the study. In total 1138 letters
were sent out; the parents of 166 boys expressed an interest in
the study (14%), and 64 (38%) signed a consent form.
&>?.C ./=318
The study was conducted in 3 phases as illustrated in Fig-
ure 1. Each boy participated in one phase only. In phase 1 we
assessed the immediate response of bone biomarkers to vibra-
tion; in phase 2, we assessed the biomarker response to re-
peated episodes of vibration; and in phase 3 the variation in
biomarkers immediately after standing on a non-vibrating
platform. Gradually increasing overall periods of vibration
were used in phase 2 because of uncertainty as to what dura-
tion of exposure (i.e. mechanical stimulation dose) would be
20<9. 
 Study design showing number of days of whole body vibration, blood sampling regime, and thermal imaging by phase of the study. 
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needed in order to generate a response in biomarkers. 
In phase 1 (immediate response), boys were randomly allo-
cated to platform type, either Juvent (low, <1.0 g magnitude) or
Galileo (high, >2.0 g magnitude). Blood samples were collected
immediately before and 10 and 60 minutes after vibration.
In phase 2 (response after repeated exposure), boys were
randomly allocated to platform type, and duration of interven-
tion. Half the boys received three cycles of vibration, the re-
mainder five cycles.
In those receiving three cycles, blood samples were taken
immediately before and 10 minutes after vibration on days 1
and 3, with a further sample being taken 2 days later.
In those receiving five cycles, blood samples were taken
immediately before and 10 minutes after vibration on days 1,
3 and 5 with a further sample being taken 3 days later.
The variation in the later sample collection timings reflected
both the need to fit with boys’ school and family commitments
(sample collection was timed to allow normal school atten-
dance and avoid weekend attendance) and the uncertainty as
to whether a biomarker response would occur either immedi-
ately or in a more delayed manner.
In phase 3, boys stood on a non-vibrating platform and sam-
ples were taken at 30 minute intervals over a 2 hour period,
similar to the timing of samples in those exposed to vibration,
in order for us to allow for any underlying time-related changes. 
A thermal image was recorded pre and post vibration of the
legs below the knee in the phase 1 boys exposed to a single 10
minute period of vibration and at 30 minute intervals (the same
time points as for blood sampling) in the control group. 
Recruitment to each phase of the study followed completion
of the previous phase. Boys were randomly assigned to vibra-
tion platform (phase 1 and 2) and number of consecutive days
of intervention (phase 2 only) by the successive opening of
opaque envelopes containing the randomisation code; the ran-
domisation to duration and platform was balanced. Neither the
participants nor the researcher could be blinded to the inter-
vention groups due to the difference in shape and size of plat-
forms and the mode of vibration. Study visits occurred in the
mornings; for the boys in phase 1 and the control group they
took place in the Clinical Research Facility at Sheffield Chil-
dren’s Hospital. Phase 2 visits took place in the child’s home
or school for participant convenience. All visits were carried
out by the same researcher (RH).
 9+.381 </137/
Participants stood either on the Galileo Advanced platform
(Novotec Medical GmbH, Pforzheim, Germany) which delivers
a high frequency high magnitude side-alternating signal, or the
Juvent MDT 1000 platform (Marodyne, Lakeland, Florida, USA)
which delivers a high frequency low magnitude synchronous
(vertical) signal. The Galileo platform was set at a frequency of
20 Hz with the boy’s feet positioned on the foot plate to give a
peak to peak displacement of 4 mm, providing a peak to peak
acceleration of approximately 6.4 g (earth’s gravity; 1 g= 9.81
m/s2), although the acceleration experience by the head is never
>1 g. The Juvent delivers 32-37 Hz, displacement 0.085 mm, at
an acceleration of approximately 0.3 g. All participants were
asked to stand barefoot on the platforms facing forward with their
knees slightly bent for 4 cycles of 2.5 minutes on the platform
and 30 seconds off, totalling 10 minutes vibration. Insertion of a
rest period between cycles of loading is thought to enhance the
anabolic response of bone35-38. A training period to familiarise
participants to the platforms was not possible as the intervention
was conducted over such a short time scale. The rest periods
therefore also helped participants to tolerate the full 10 minutes
of vibration from day 1.
#?>-97/ 7/+=?</=,699. =+7:6381
Blood samples were collected to measure the bone forma-
tion markers pro-collagen type 1 N-terminal propeptide
(P1NP; Elecsys, Cobas E411, Roche Diagnostics, UK; intraas-
say %CV <1.7%) and osteocalcin (OCN; Cobas E411, Roche
Diagnostics, Germany; intraassay %CV 1.4-3.3%), and the
bone resorption marker C-terminal cross-linked telopeptide of
type 1 collagen (CTx; Elecsys β-CrossLaps/serum kit, Cobas
E411, Roche Diagnostics, UK; intraassay %CV 2.8-8.4%).
Factors affecting bone resorption - osteoprotegerin (OPG;
ELISA, BioVendor, Czech Republic; intraassay %CV 2.5-
4.9%) - and bone formation - sclerostin (SCL; Enzyme Im-
munoassay, Biomedica Gruppe, Germany; intraassay %CV
<7%) - were also measured. Sampling was undertaken as per
Figure 1. All samples were collected in the mornings starting
at approximately 08:00 following an overnight fast. Samples
were centrifuged, separated and stored at -80oC within 2 hours
of collection. Serum samples were assayed in duplicate. P1NP,
CTx OPG and SCL were assayed for each sample; OCN only
for the baseline and day 8 samples in those receiving 5 days
of vibration (insufficient sample for intermediate measures).
'2/<7+6 37+1381
Thermal images of the legs below the knee were obtained
pre- and post vibration on boys exposed to 1 day only of WBV
(n=12) and on half of the boys (randomly selected) in the con-
trol group (n=7) to measure skin surface temperature. Images
were recorded with the participants standing on the platform
prior to commencement of WBV and immediately upon com-
pletion of the 4 cycles of vibration. Boys in the control group
were asked to stand on and off the Juvent platform at the same
timing as for the boys exposed to WBV, with the platform
turned off. Images were captured using a hand held Land
Guide M4 thermal imaging camera (Asten Instruments Ltd,
Market Rasen, UK) with a temperature range of -20oC to
250oC and a sensitivity of 0.12oC, CV 2%, and were analysed
using the manufacturer’s software. All images were recorded
by one of two of the researchers (CH or HR) in the same room
with windows and doors kept closed and blinds drawn to block
out sunlight and/or draughts. As the region of interest was the
surface area over the gastrocnemius and soleus muscles, boys
were asked to wear shorts or to roll their trouser legs up above
their knees. Thermal images were recorded as a non-invasive
surrogate measure of blood flow to the skin over the calf mus-
R. Harrison et al.: Rapid bone response to vibration
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cles following WBV to detect if there was a difference in blood
flow due to muscular activity in boys exposed to the low or
high magnitude WBV.
B/<-3=/ +8. +8>2<9:97/><C
Participants were asked about the amount of exercise and
sport activity they had taken part in over the 7 days prior to their
first study visit using the validated Godin-Shepard Leisure-Time
questionnaire39. The frequency and intensity of the types of ex-
ercise given in answer to these questions were multiplied by the
anticipated metabolic equivalents (METs) of nine, five, and
three for strenuous, moderate, and mild exercise respectively, to
provide an activity score for comparison. Boys were not asked
to alter their normal activities for the duration of the study.
Weight was measured to the nearest 0.1 kg with the child wear-
ing light clothing using electronic balance scales (Seca GmbH
& Co, Hamburg, Germany). Height was measured to the nearest
0.1 cm without shoes using a portable stadiometer (Leicester
height measure, Invicta, Leicester, UK). Pubertal status (Tanner
stage) was determined during interview by self-assessment
using a gender appropriate validated pictorial scale depicting the
different stages of puberty40. Boys who indicated that they were
at Tanner stage 2 or above were excluded from the study. 
&>+>3=>3-+6 +8+6C=3=
No sample size calculation was performed as this was a pilot
study to determine the rate and range of acute responses in
markers of bone turnover and bone-derived factors to WBV.
Statistical analysis was performed using SPSS version 19
(IBM, New York, USA). Statistical significance testing of
baseline characteristics was not performed41. 
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A repeated measure ANOVA was used to assess within
group changes in phase 1 up to time 60 minutes post-vibration.
Day 1 data from phase 1 and phase 2 boys were combined to
assess the immediate bone biomarker response to vibration
(i.e. comparing pre-vibration vs immediately post-vibration).
Paired t-tests were used to test for change within a group from
pre-vibration to immediately post-vibration on each day (day
1, day 3 and day 5). The within group differences are reported
as percentage changes as this allows the reader an understand-
ing of the magnitude of change for the individual subjects. 
/>A//8 1<9?: .300/</8-/=
Changes in bone markers (P1NP, CTx) and bone cell-derived
factors (OPG, SCL) at day 1 pre to immediately post-vibration
were compared between high and low magnitude WBV and
control groups using ANOVA and ANCOVA (adjusting for
baseline bone turnover markers, number of days of vibration,
age, activity score). Activity score was included as a covariate
to adjust for observed baseline imbalances. Adjustment for days
of vibration was included to account for the recruitment of
groups of subjects in successive phases (day 1 data is combined
from phase 1 and 2). This adjusts for potential differences be-
tween the boys recruited in the different phases.
Changes in bone markers (P1NP, CTx) and bone cell-de-
rived factors (OPG, SCL) pre to 60 minutes post-vibration on
 7> 5*062;<-.  201 5*062;<-.  76;974 
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!.*6 & 6 !.*6 & 6 !.*6 & 6
Age (years) 10.4 0.8 18 10.4 0.9 18 10.8 0.6 15
Height (cm) 141.8 6.5 18 145.4 8.5 18 143.2 7.0 15
Weight (kg) 34.3 4.0 18 37.1 6.8 18 38.6 10.9 15
Body Mass Index (kg.m-2) 17.1 1.7 18 17.4 1.8 18 18.6 4.1 15
Activity score (METS units) 79 25 18 94 33 18 67 26 15
P1NP Day 1Pre (ng/ml) 671.5 281.1 18 794.5 204.6 17 679.5 186.5 14
OCN Day 1Pre (ng/ml) 86.4 15.5 5 88.3 32.2 5 - - -
CTx Day 1Pre (ng/ml) 1.85 0.55 18 2.00 0.48 17 1.91 0.40 14
OPG Day 1Pre (pmol/L) 3.67 0.53 16 3.71 0.97 17 3.07 0.46 14
SCL Day 1 Pre (pmol/L) 25.54 6.25 16 29.13 6.22 17 24.25 7.11 14
Time between samples day 1 (minutes) 33.06 17.01 17 29.76 5.21 17 31.07 2.27 14
& =>+8.+<. ./@3+>398 8 8?7,/< 90 :+<>3-3:+8>=
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'*+4. 
 Baseline characteristics of participants by intervention group.
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day 1, and pre to immediately post-vibration on day 3 and day
5 were compared between groups using ANOVA and AN-
COVA (adjusting for baseline bone turnover marker). No other
covariates were included due to lack of power. After day 1 data
was only collected in boys exposed to the vibration (high and
low magnitude WBV groups, not the control group); the com-
parison for day 3 and day 5 are between WBV groups only. 
97,38/. -2+81/ +> .+C  
Change in bone markers (P1NP, CTx, OCN) and bone cell-
derived factors (OPG, SCL) after 5 days of vibration were
combined across the WBV groups due to limited data. Paired
t-tests were used to test for change from baseline using day 1
(pre-test) and day 8 measurements. 
*@ 
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5.*6   6 5.*6   6 5.*6   6 "#(
P1NP 10 min post -61.3 (-103.9 to -18.8) 14 -67.6 (-108.7 to -26.5) 17 -71.3 (-164.5 to 21.8) 16 0.97
ng/ml 60 min post -83.7 (-135.1 to -32.2) 14 -58.5 (-160.1 to 43.0) 6 -16.5 (-172.4 to 139.4) 5 0.43
CTx 10 min post -0.11 (-0.21 to 0.05) 14 -0.17 (-0.25 to -0.09) 17 -0.08 (-0.21 to 0.05) 16 0.36
ng/ml 60 min post -0.14 (-0.27 to -0.02) 14 -0.17 (-0.37 to 0.03) 6 -0.07 (-0.15 to 0.01) 5 0.64
*@ 
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P1NP 10 min post -71.6 (-160.4 to 17.3) 14 -70.7 (-122.6 to -18.9) 17 -64.8 (-121.6 to -8.0) 16 0.91
ng/ml 60 min post -76.6 (-131.4 to -21.7) 14 -75.6 (-155.4 to 4.1) 6 -15.8 (-123.4 to 91.7) 5 0.17
CTx 10 min post -0.11 (-0.27 to 0.05) 14 -0.17 (-0.26 to -0.07) 17 -0.09 (-0.19 to 0.01) 16 0.14
ng/ml 60 min post -0.15 (-0.26 to -0.03) 14 -0.20 (-0.37 to -0.03) 6 -0.02 (-0.25 to -0.21) 5 0.59
.4?=>/. 09< ,+=/638/ 'B$	"$ 6/81>2 90 ></+>7/8> +1/ +->3@3>C =-9</ >37/ ,/>A//8 =+7:6/=
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'*+4.  Change in serum P1NP and CTx values from baseline at 10 and 60 minutes post WBV by platform group.
 7> 5*062;<-. 84*;/795 201 5*062;<-. 84*;/795 76;974
" !.*6 & 8 =*4<. " !.*6 & 8 =*4<. " !.*6 & 8 =*4<.
$
"$ 6054  Day 1 pre 17 669.8 289.7 			 16 786.8 208.8 0.12 14 697.5 186.5 			
Day 1 10 mins post 602.2 245.5 715.4 191.6 618.2 141.7
Day 1 pre* 6 600.6 409.7 0.2 5 830.1 287.3 0.78 14 697.5 186.5 		
Day 1 60 mins post 542.1 332.7 813.6 249.4 595.8 194.5
Day 3 pre 11 703.2 184.4 			
 10 749.8 122 			 - -
Day 3 post 575.6 139.3 646.8 103.8 - -
Day 5 pre 5 712.6 212.7 			 4 763.7 169.4 		 - -
Day 5 post 608.9 225 681 145 - -
'? 6054  Day 1 pre 17 1.83 0.56 			
 16 2.00 0.50 0.2 14 1.91 0.40 		
Day 1 10 mins post 1.67 0.49 1.93 0.50 1.80 0.45
Day 1 pre 6 1.71 0.73 0.08 5 2.40 0.59 0.08 14 1.91 0.40 		
Day 1 60 mins post 1.54 0.65 2.34 0.56 1.76 0.39
Day 3 pre 11 1.89 0.51 			 10 1.93 0.30 0.2 - -
Day 3 post 1.76 0.47 1.86 0.28 - -
Day 5 pre 5 1.91 0.66 			 5 1.99 0.16 0.9 - -
Day 5 post 1.76 0.62 2.01 0.33 - -
!/+8 :</ +8. :9=> *) $	"$ +8. 'B :/< 38>/<@/8>398 1<9?: 09< =+7:6/= 38-6?./. 38 >2/ :+3</. >>/=> +8+6C=3= 90 :</ +8. :9=> @+6?/= 98 /+-2 .+C
90 =+7:6/ -966/->398
&  =>+8.+<. ./@3+>398 "  8?7,/< 90 :+<>3-3:+8> =+7:6/= 38-6?./. 38 >2/ +8+6C=3=
#86C :+<>3-3:+8>= +669-+>/. >9 	 .+C 90 *) 9< -98><96 1<9?: 2+. ,699. -966/->/. +>  738?>/= :9=> *) 9< /;?3@+6/8> >37/ 38 >2/ -98><96 1<9?:
>2/=/  ,9C= +</ + =?,1<9?: 90 >2/ 	 7/+=?</. 98 .+C 	
'*+4.  Mean (SD) bone turnover marker (P1NP, CTx) values Pre and post WBV on days 1, 3, 5.
R. Harrison et al.: Rapid bone response to vibration



To account for camera temperature drift between the
recorded images, the post-image temperature was adjusted and
within participant temperature change pre to post WBV re-
ported as the outcome. For each participants’ pre- and post
image a reference area not expected to change in temperature
over the short time lapse between the images (i.e. where the
camera was pointed at the wall) was determined with the re-
gion temperature recording used to adjust for any camera drift.
%.:<4;:
In total 64 boys consented to study participation. Of these 8
were excluded on the basis of pubertal stage greater than Tanner
1, 2 withdrew consent prior to data collection and commence-
ment of the intervention, and 3 withdrew due to difficulties in
obtaining blood samples on day 1. Data was collected and
analysed on 51 boys in total; 12 boys in phase 1 (1 day/10 min-
utes only of WBV), 24 boys in phase 2 (3 or 5 days of WBV,
12 subjects in each group), and 15 boys in the control group
(no WBV); see Figure 1. The baseline characteristics of each
group are shown in Table 1. No formal statistical testing was
undertaken. Age, height, body mass index (BMI), and weight
were similar between the groups. The activity scores may ap-
pear to be different across the intervention groups with the high
magnitude group scoring higher but it should be noted that
these scores have a large standard deviation (SD). Baseline
P1NP, OCN, CTx, OPG, and SCL values were similar between
the groups. The time taken between the pre and post vibration
samples on day 1 was slightly longer in the Juvent group. One
boy in this group felt faint after cannulation and rested prior to
standing on the vibration platform, accounting for the greater
time lag and larger SD in this group.
98/ >?<89@/< 7+<5/<= D -2+81/= +-<9== 38.3@3.?+6 -C-6/= 90
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Within control group (n=14)
P1NP decreased by 7.8% (CI -13.4 to -2.2; p=0.008, paired
t-test) at 10 minutes, and by 12.0% (CI -19.3 to -4.7; p=0.04)
at 60 minutes compared to baseline. Osteocalcin was not meas-
ured. CTx decreased by 12.0% (CI -19.3 to -4.7; p=0.04) at 10
minutes and by 7.0% (CI -13.7 to-0.4; p=0.03) at 60 minutes
(actual values, Table 2). 
Within low magnitude group, first cycle of vibration (n=17)
P1NP decreased by 7.9% (CI -14.0 to -1.9; p=0.003, paired
t-test) at 10 minutes, and by 0.18% (CI -20.6 to 21.0; p=0.20)
at 60 minutes (n=5). CTx decreased by 6.2% (CI -12.2 to -0.2;
p=0.04) at 10 minutes post WBV and by 9.4% (CI -21.1 to 2.2;
p=0.08, statistically not significant) at 60 minutes post vibra-
tion (actual values Table 2).
Within high magnitude group, first cycle of vibration (n=16)
No change was seen in P1NP (decreased by 6.8% CI -18.4
to 4.9; p=0.1) at 10 minutes, and by 6.04% (CI -9.2 to 21.3
p=0.78) at 60 minutes (n=6). Neither was there a change in
CTx at 10 minutes (n=16; 3.6% decrease observed, CI -9.9 to
2.8; p=0.2) or 60 minutes (2.6% decrease; CI -5.4 to 0.1;
p=0.08; actual values Table 2).
There were no changes in either osteoprotegerin or scle-
rostin over the period from baseline to 60 minutes post WBV
for either low or high magnitude WBV.
Changes across individual vibration cycles; Day 3 and Day 5
On day 3 P1NP decreased pre to post vibration in the low
magnitude group (n=11) by 17.5% (CI -22.6 to -12.5; p<0.001)
and in the high magnitude group (n=10) by 13.3% (CI -20.2 to
-6.3; p=0.004). CTx decreased following WBV in the low mag-
nitude group by 6.2% (CI -10.4 to -2.1; p=0.007; n=11), but did
not change in the high magnitude group (day 3: 3.4% decrease
observed, CI -8.1 to 1.3 p=0.2; n=10; actual values Table 3). 
Day 5 showed a decrease following WBV in P1NP in the
low magnitude group (n=5) of 15.9% (CI -20.2 to -6.3;
p=0.008) and in the high magnitude group (n=4) of 10.6% (CI
-20.2 to -0.9; p=0.05; Table 3). CTx decreased following WBV
in the low magnitude group by 8.1% (CI -10.3 to -5.7;
p=0.004; n=5) and was unchanged in the high magnitude
group (0.5% increase observed, CI -16.5 to 17.4; p=0.9; n=4;
actual values Table 3).
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There were no differences between the control and platform
groups in the day 1 P1NP and CTx response to vibration
(ANOVA and adjusted ANCOVA; Table 2). There was also no
difference between the platform groups in response to WBV
on days 3 and 5 from immediately pre-vibration to 10 minutes
after vibration (no control data collected) though as on day 1
within group changes were detected, as shown above. 
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Bone turnover markers – P1NP, OCN, CTx
In contrast to the decrease shown in the immediate pre to
post WBV time period, boys exposed to 5 consecutive days of
WBV (platform groups combined, n=11, measurements on day
8 vs baseline measurements) had a significant increase in
P1NP of 25.1% (CI 12.3 to 38.0; paired t-test p=0.005; Figure
2). No significant change was detected in the formation marker
OCN (measured at day 1 and day 8 in the 5 day subjects only
n=11; change +11.5% CI -8.3 to 31.2; p=0.2; Figure 2). At day
8, CTx was greater in the boys exposed to 5 days of WBV on
both of the platforms than at baseline with an increase of
10.9% (CI 3.6 to 18.2; paired t-test p=0.009; Figure 2).
OPG and sclerostin
OPG and sclerostin were analysed at each time point. OPG
showed a trend for an increase of 7.2% (CI -1.4 to 15.8;
p=0.08) on day 8 compared to baseline (n=11; Figure 3). No
difference was detected at any other time point within or be-
tween groups. Additionally no change within or between
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groups was detected at any time point for sclerostin (change
of +7.2% CI -7.45 to 21.73; p=0.3). 
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Thermal images were captured on 7 boys in the control
group and on all boys exposed to 1 day only of vibration (n=7).
However it was not possible to compare images in 2 of the
boys and these were excluded from the analysis. Images there-
fore were analysed on 5 boys exposed to each of the vibrating
platforms and 7 boys from the control group. The change in
skin surface temperature pre- to post vibration ranged from -
1oC to 1.6oC (mean 0.3oC, CI -0.4 to 1.1) in the control group,
1.4oC to 4.2oC (mean 2.9oC, CI 1.5 to 4.4) in the high magni-
tude group, and 0.2oC to 2.8oC (mean 0.9oC, CI -0.4 to 2.3) in
the low magnitude group. There was a significant difference
in the response of the boys in the high magnitude group com-
pared to the control (p=0.002) and low magnitude groups
(p=0.02; ANOVA, bonferroni post hoc test). In addition, when
visually assessing the pre and post images, a difference in the
temperature distribution was seen in the boys exposed to the
high magnitude platform that was not seen in the control or
low magnitude groups (Figure 4).
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WBV was well tolerated by the study participants. Minimal
side effects were reported; itching or “weird feeling” in the
calves or legs (high magnitude), tickling sensation in the feet
(low magnitude) and anxiety in relation to cannulation. In all
cases these resolved on or shortly after completion of the WBV. 
2:,<::276
We observed a fall in both P1NP and CTx ten minutes after
vibration using the low magnitude platform on days 1, 3 and
5 and on days 3 and 5 following vibration using the high mag-
nitude platform. Similar reductions were seen, however, in
boys who stood on a platform that did not vibrate over the
same time period. There were no differences between the
groups in the changes in P1NP or CTx across the individual
cycles of vibration exposure.
20<9.  Boxplots illustrating the absolute values of a) P1NP, b) Osteocalcin and c) CTx at baseline and day 8 for boys exposed to 5 consecutive
days of WBV.
20<9.  Boxplots illustrating the absolute values of a) OPG and b) Sclerostin at baseline and day 8 for boys exposed to 5 consecutive days of WBV.
R. Harrison et al.: Rapid bone response to vibration



By contrast, five consecutive days of WBV (both groups
combined) increased the bone formation marker P1NP by
25.1% and bone resorption marker CTx by 10.9% between the
pre-vibration baseline and the day 8 measurement. The second
bone formation marker measured, osteocalcin, did not change
over the period of observation. This may be because osteocal-
cin is produced later in the process of endochondral ossifica-
tion, when mineralisation is taking place. By contrast, P1NP
is produced early in the bone formation process, when the os-
teoid matrix is being formed and deposited.
The greater increase over the 8 day period in the formation
marker as opposed to the resorption marker suggests that there
is an uncoupling of bone turnover in favour of formation in re-
sponse to vibration. These changes are consistent with the re-
ported effects of increased activation of the canonical
wnt-signalling pathway through LRP5/6 where bone formation
is increased and there is increased osteoblastic expression of
osteoprotegerin. Our data indicated this with a trend towards
an increase in OPG. However increased expression of OPG
should also be associated with reduced bone resorption which
is not confirmed by our CTx results. 
Sclerostin is widely recognised to be a key inhibitor of bone
formation by the canonical wnt-signalling pathway through
LRP5/642 and is an important factor in bone response to me-
chanical loading43. However no significant change in serum
sclerostin was detected either over time or between groups and
could not therefore explain our observations of increased
P1NP. Animal studies have shown down-regulation of scle-
rostin production at sites of new bone formation following
even short periods of mechanical loading43. It may be the case
that changes in serum sclerostin do not reflect accurately or
quickly on changes occurring at a tissue level. An alternative
explanation is that the rapid changes observed in bone forma-
tion and resorption here were the result of activity either in
other pathways, or in other regulators of the wnt-signalling
pathway through LRP5/6. Additional inhibitors of the pathway
are well described, including DKK1 and WISE, both secreted
by osteocytes. PTH inhibits the production of both sclerostin
and DKK1 and also interacts via the PTH-PTHR1 complex
with LRP6, initiating signalling in the absence of Wnt-lig-
ands44. It will be important in future studies to include such
factors to understand the underlying physiological basis of
acute responses to mechanical loading.
Other studies that have looked at bone turnover marker re-
sponse to WBV have been conducted in adult populations. Cor-
rie et al45 found an increase in P1NP of 17.5% in adults aged 64
years and over exposed to either synchronous or side-alternating
vibration for 12 weeks, but no change in CTx. This suggests, as
shown in our paediatric population, that bone marker response
is not dependent on the method of vibration. In contrast to the
increase we saw in resorption, Turner et al46 showed a 34% de-
crease in urinary NTx following 6 weeks of WBV in post-
menopausal women, a third of whom had osteoporosis.
Following one episode of vibration and exercise Sherk et al47
also found a decrease in CTx in healthy young women exposed
to one episode of high magnitude synchronous WBV. The de-
20<9.  a) Thermal images taken immediately before and after vi-
bration. b) Boxplots showing comparison of the pre to post vibration
temperature change between the groups.
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crease was greater at 30 minutes post exercise when the women
were exposed to WBV immediately prior to resistance exercise
than following resistance exercise only (-12.5% vs -1.3%).These
studies demonstrate a change in bone turnover markers that sug-
gests an uncoupling of bone turnover in favour of formation as
we found in our paediatric population. However, Rubin et al24
found only a slight decrease of 3% in the resorption marker hy-
droxyproline in their active vibration group with a much greater
decrease in the placebo group of 16%. In accord with our data
others have failed to demonstrate a change in the formation
marker osteocalcin following WBV24,27,30.
Our focus on children and the response of bone in the grow-
ing skeleton rather than on a fully developed skeleton may ex-
plain some differences seen between our results and those of
others. The increase in resorption and greater increase in for-
mation in our group, not typically seen in the adult popula-
tions, may reflect the enhanced response to loading that has
been well reported in the growing as opposed to adult skeleton.
Five separate papers24,27-30 found no change in bone markers
following 6-12 months WBV in healthy young adults and post-
menopausal women, but this may reflect the adaptation of
bone structure and bone remodelling to the continuing stimulus
over a prolonged period. 
The mechanism of the bone response to WBV is thought to
be due to a direct response within the bone tissue to loading or
via muscle; either by contractions loading the bone or due to
increased muscle mass and/ or force increasing load to bone48.
Increased muscle activity and blood flow as a result of WBV
have been reported in a number of studies49-55. To determine if
muscle activation following WBV was different between the
low and high magnitude groups our study recorded skin surface
temperature of the lower leg, as a surrogate measure, pre and
post vibration in a sub group of boys. Although we found no
difference between groups in bone turnover marker response
in the immediate pre to post vibration period, thermal imaging
detected a 31% greater increase in skin surface temperature in
boys exposed to the high magnitude versus the low magnitude
platform. Skin surface temperature has been shown to be in-
creased in passive vibration56 as well as weight bearing vibra-
tion57 suggesting that some degree of muscle activation occurs
regardless of the magnitude or method of the stimulation. Nev-
ertheless, our results suggest muscle activation is not a prereq-
uisite for bone to respond to mechanical stimulation.
In terms of possible future application, we speculate that
this approach might have utility in identifying subjects more
likely to benefit from vibration exercise-based interventions
to increase bone mass; to identify potential adverse “damping”
effects from pharmacological therapies targeting bone; and to
assess the responsiveness of the skeleton to vibration in dif-
ferent disease states.
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This study was designed as a pilot study to determine the
size and variability of the response of bone turnover markers
to vibration and was therefore not powered to detect any spe-
cific degree of change. The intervention and control groups
had relatively small numbers and so the study findings must
be regarded as preliminary. Whilst the study has met its aim
of identifying the rate and range of response of bone turnover
markers in pre-pubertal boys to WBV it is not clear if the same
response would be detected in pre-pubertal girls, or during
other stages of growth. 
The instructions regarding stance (stand with knees slightly
bent) were the same for the subjects irrespective of platform;
whilst appropriate for the high magnitude device, this stance
may have abrogated the skeletal response to low magnitude
stimulation.
The length of time between the last period of vibration and
collection of the final samples was different between the boys
exposed to 3 or 5 days of vibration, 48 and 72 hours respec-
tively, due to logistical issues. The thermal imaging produced
interesting data, however there were some limitations in our
methods. A drift in the temperature reading of the camera was
observed during the study and the distance of the camera to
the point of interest (the boys leg’s) was not standardised be-
tween participants. Our findings could however be confirmed
in future studies using more robust techniques and methods
such as use of a thermal imaging suite.
&?77+<C
Five consecutive days of WBV increased the bone forma-
tion marker P1NP by 25.1% and the resorption marker CTx
by 10.9%, demonstrating an alteration in bone turnover that is
in favour of bone formation. The direct mechanism of this
acute response is not clear as sclerostin was unchanged by vi-
bration in this study and OPG increased but so did bone re-
sorption. Studies in healthy adult populations have been unable
to demonstrate an anabolic effect of WBV on bone over longer
periods, but we have shown here that bone in a healthy grow-
ing skeleton does have the capacity to respond quickly to
WBV irrespective of the magnitude of that vibration. The pos-
sible broader application of this approach in other settings re-
quires careful evaluation, but these initial data are encouraging
in terms of the size and consistency of response across differ-
ent types of vibration platforms.
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